(Total Views: 408)
Posted On: 04/16/2020 10:48:24 AM
Post# of 153863
You can forget about selling to other countries.
Leronlimab is even more unknown in other countries.
There are no foreign trials (I believe NP mensioned UK I believe, but can find it).
Which foreign doctors/hospitals/insurers/health regulators are going to buy this unknown stuff?
Sorry, but first class BS.
Stick to the good old US of A, where we're marginally known and hated by the FDA.
Far better chances.
Edit; in my country there trying everything that BP has got to offer. No one ever heard of Leronlimab and no one is going to give it a try. Don't feel that'll be different in any other EU country.
BTW: never heard a thing from Italy too. Weren't they supposed to give L a try?
Leronlimab is even more unknown in other countries.
There are no foreign trials (I believe NP mensioned UK I believe, but can find it).
Which foreign doctors/hospitals/insurers/health regulators are going to buy this unknown stuff?
Sorry, but first class BS.
Stick to the good old US of A, where we're marginally known and hated by the FDA.
Far better chances.
Edit; in my country there trying everything that BP has got to offer. No one ever heard of Leronlimab and no one is going to give it a try. Don't feel that'll be different in any other EU country.
BTW: never heard a thing from Italy too. Weren't they supposed to give L a try?
(2)
(0)
